Hospital Technology Transfer and Commercialization Offices

Technology transfer is one of the oldest hospital commercialization structures in the public record. In the first directory prototypes, it rarely stands alone. The offices below combine intellectual property management with licensing, company creation, or venture activity. In the broader hospital innovation landscape, technology transfer is the function most directly connected to moving research assets toward external adoption.

Offices that describe themselves as the system's commercialization arm

Cleveland Clinic Innovations is described in official materials as the function that turns Cleveland Clinic inventions into medical products and companies. The 2025 year-in-review states that the program has operated for 25 years and that its work now includes digital health, therapeutics, and diagnostics in addition to medical devices.

Mayo Clinic Ventures, housed in the Department of Business Development, states that it licenses Mayo Clinic intellectual property, forms companies, teaches entrepreneurism, runs a business accelerator, and participates in venture investing. Official FAQs say the technology portfolio is too large and fluid to maintain a static public list.

Mass General Brigham Innovation states that it coordinates industrial relationships and intellectual property management across the system's hospitals and that it licenses technologies in diagnostics, devices, research tools, software, therapeutics, and vaccines.

Pediatric technology transfer

Boston Children's Technology and Innovation Development Office states that it manages all intellectual property arising from the hospital and that it supports development through the Therapeutic and Medical Device Accelerator. Official pages also describe startup formation as one available route.

CHOP Innovation Ventures presents licensing, business development, contracting, and investment professionals as the gateway for researchers seeking to commercialize discoveries. The hospital's 2015 Office of Entrepreneurship and Innovation remains part of the public record and described investment capital as one tool for preparing assets for a commercial exit or new company.

Technology transfer beside an accelerator

Cedars-Sinai Technology Ventures is described in an official newsroom article as managing more than 500 technologies and more than 1,100 patents. The same enterprise operates the Cedars-Sinai Accelerator, now presented as Accelerator+.

That pairing is worth noting as a structure, not as a score. One function commercializes internal inventions. The other brings external companies into the health system.

What executives should take from the public record

A technology-transfer office answers a specific question: who owns the invention, who protects it, and who is allowed to license or form a company around it. It does not automatically answer whether the system has customers, sales capability, or a route to market for non-patent assets such as services, education, or operations.

See the technology transfer and licensing pages for the current sourced set.

How does your innovation program compare? Request a confidential conversation about the commercial opportunities, market pathways, and capabilities within your hospital's innovation portfolio.